Sparsentan has toxicity warning particularly related to liver toxicity, foetal toxicity and certain drug interactions - “the company will have to run a risk evaluation and mitigation strategy, or REMS, as part of the approval. It will require doctors to go through special training, and patients to be enrolled in a monitoring program, in order for the drug to be prescribed.”
Sparsentan has toxicity warning particularly related to liver...
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
36.0¢ |
Change
-0.015(4.00%) |
Mkt cap ! $200.8M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 37.5¢ | 36.0¢ | $457.0K | 1.248M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 28883 | 36.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.5¢ | 51411 | 2 |
View Market Depth
| Last trade - 16.10pm 18/11/2024 (20 minute delay) ? |
| DXB (ASX) Chart |